ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671175 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671175; 2) Community: the network communities that were significantly associated with the response to NSC 671175; 3) Molecule: the relationships between components within communities and NSC 671175; 4) MDR: the compounds that were significantly associated with the NSC 671175.

NSC Compound Enrichment Correlation
NSC 748705 Null 0.0284045326811618 0.21617122
NSC 749152 Null 0.0284045326811618 0.27687418
NSC 751500 Null 0.0284045326811618 0.039299951
NSC 759274 ARSENIC TRIOXIDE 0.0284045326811618 -0.044119689
NSC 104801 Cytembena 0.0286383688883668 -0.071754196
NSC 13275 Null 0.0286383688883668 0.063400659
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0286383688883668 0.010423428
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0286383688883668 -0.12661409
NSC 135073 WITHACNISTIN 0.0286383688883668 -0.09901897
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0286383688883668 -0.015401403
Total:73  Current:40    [First] [Prev] [Next] [Last]